X-ray scattering technique pinpoints new targets for antibiotic drug development
Researchers from City St George's, University of London, have used a new ultra-high precision X-ray scattering technique to reveal the location and identity of metal ions in bacteria that are crucial ...
LXRβ emerges as a promising target for depression and anxiety treatments
In a state-of-the-art Bench to Bedside review published in the journal Brain Medicine (Genomic Press), researchers Dr. Xiaoyu Song and Professor Jan-Åke Gustafsson from the University of Houston and Karolinska Institutet (Sweden) shed light on the therapeutic potential of liver X receptor beta (LXRβ) in treating depression and anxiety.
Identical twins study uncovers insights into multiple sclerosis mechanisms
Multiple sclerosis (MS) is a chronic inflammatory disease in which the immune system attacks the central nervous system.
New X-ray technique reveals metal ion role in antibiotic efficacy
Researchers from City St George's, University of London have used a new ultra-high precision x-ray scattering technique to unveil the location and identity of metal ions in bacteria that are crucial for antibiotics to work optimally.
Study unravels the unique patterns of brain shrinkage in Alzheimer's disease
The way in which brains shrink in those who develop Alzheimer's disease follows no specific or uniform pattern, finds a new study by researchers at UCL and Radboud University in the Netherlands.
Study identifies ophthalmic acid as an alternative to dopamine in motor control
A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson's and other movement diseases.
Study identifies a new target for developing atrial fibrillation therapy
A new study by researchers at the University of Arizona College of Medicine – Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrial fibrillation, the most common type of abnormal heart rhythm.
Collaborative study investigates underlying cause of neuropsychiatric symptoms in Parkinson's disease
Parkinson's disease is most known for its movement-related symptoms: tremors and rigidity, slowness and falls, caused by the loss of the brain's dopamine-producing neurons.
New drug could extend the lives of breast cancer patients
LMU researchers have successfully tested a new drug which can significantly extend the lives of breast cancer patients.
Hyderabad-based INCOIS scientists map mackerel movement to aid in fishing success
INCOIS uses science to map fish movements, saving fishermen time and money, with AI predicting mackerel hotspots.
New framework established for defining prebiotics
The concept of prebiotics – defined as substrates that are selectively utilized by host microorganisms conferring a health benefit – was introduced in the scientific community nearly 30 years ago.
Study reveals bias in substance use screening for injured adolescents
Injured adolescents from marginalized groups treated at pediatric trauma centers are more likely to be tested for drugs and alcohol than white adolescents, even when accounting for injury severity, a study led by researchers at UCLA and Children's Hospital Los Angeles suggests.
last updated on 5 Oct 14:27